BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

North America

Innovent Biologics and Roche Forge Strategic Alliance to Advance DLL3-Targeted ADC for Small Cell Lung Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

January 02, 2025 | News

I Peace Achieves Milestone of Manufacturing 100 GMP-Grade iPS Cell Lines

Leading GMP cell CDMO I Peace, Inc., specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the n...

December 31, 2024 | News

Exicure Signs MOU to Acquire GPCR USA and Advance Collaborative Research in Drug Development

Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with GPCR ...

December 30, 2024 | News

WuXi AppTec Divests Advanced Therapies Unit Amidst US BioSecure Act Scrutiny in Strategic Deal with Altaris, LLC

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life scie...

December 27, 2024 | News

BioPharma America: The Exclusive News Portal for the U.S. Biopharma Industry

The biopharmaceutical landscape in the United States now has its dedicated media hub - BioPharma America. Designed as the premier destination for all ...

December 24, 2024 | News

New Therapeutics Venture GEMMABio Secures $34M in Seed Funding to Accelerate Gene Therapy Initiatives

Significant international investment defies sector trend GEMMA Biotherapeutics ("GEMMABio") – a new therapeutics company founded by gene therapy pio...

December 24, 2024 | News

Vertex Announces FDA Approval of ALYFTREK™: A Once-Daily CFTR Modulator for Cystic Fibrosis Patients Aged 6 and Older

ALYFTREK™ is approved for patients 6 years and older with at least one responsive mutation, including 31 additional mutations not re...

December 23, 2024 | News

PeproMene Bio Secures $11M Investment to Advance BAFF-R CAR T Therapy for Relapsed Follicular Lymphoma

Based on promising early clinical results from PeproMene Bio's PMB-102 Phase 1 study, they will receive $6M USD upfront plus an addit...

December 20, 2024 | News

Prenetics' IM8 Partners with Mayo Clinic to Pioneer Next-Generation Premium Supplements

Prenetics' (NASDAQ:PRE) IM8, a premium supplements brand focused on science-driven health solutions, is excited to announce a collaboration through a know-...

December 20, 2024 | News

Complete Genomics Partners with Eurofins Clinical Enterprise to Expand Access to Advanced Sequencing Services

Complete Genomics, a San Jose, California based genomics tools manufacturer, announced Framingham, Massachusetts based Eurofins C...

December 18, 2024 | News

Thermo Fisher Launches MagMAX™ Sequential DNA/RNA Kit to Simplify Genomic Analysis for Blood Cancer Research

Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ Sequential DNA/RNA kit to enable clinical and translational researchers...

December 18, 2024 | News

OmniAb Showcases Multispecific Antibody Workflow and Launches OmniHub™ at AETC 2024

Presentations included a case study of the workflow for building multispecifics and the launch of OmniHub™, a bioinformatics tools platform ...

December 17, 2024 | News

Nona Biosciences and Candid Therapeutics Collaborate to Advance Next-Generation T-Cell Engagers for Autoimmune Diseases

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), announced a research collaboration and lic...

December 17, 2024 | News

Hong Kong’s Viva Biotech Expands Global Footprint with Strategic Boston Branch Launch

Viva Biotech Holdings Group ("Viva Biotech") announced the official establishment of its new branch in Boston, USA. As a global leader in drug re...

December 12, 2024 | News

Stay Connected